Abbott initiates pivotal trial for Cephea device to treat mitral heart valve disease
ABT•Abbott Laboratories initiated a pivotal trial for its Cephea device, a treatment for mitral heart valve disease.
1. Pivotal trial
Abbott Laboratories initiated a pivotal trial for its Cephea device, an innovative treatment for mitral heart valve disease.
